John Kanzius' anticancer device may have witnessed human trials

The anticancer device, invented by former JET 24 co-owner and radio and television engineer John Kanzius, could soon be sent for human trials. NeoTherma Oncology has reportedly filed with the FDA to begin human trials, the website states. The company owns the patent for the Kanzius technology, which was sold by the Kanzius family after John's death. Kanzius invented the technology while trying to find a cure for the leukemia that was ravaging his own body. During his cancer treatment travels, Kanzius told JET 24 that he has heart failure due to the number of children battling cancer and the effects of chemotherapy. He promised there had to be a better way.